Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of nephrotoxic effects of iodixanol vs ioversol in high-risk cardiac patients
2004-004086-15Phase 4Completed
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in contrast-induced nephropathy (CIN) comparing Iodixanol (Visipaque 320) with Ioversol (Optiray 350) (2 arms). Started May 2005; status: completed.
02
Drugs
iodixanolioversol
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on 2004-004086-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004086-15.